News tagged with 'Zyban'

The FDA has received so many reports of Chantix and Zyban users experiencing depression, hostility, agitation, and suicidal thoughts and commiting acts of suicide, that today the agency issued a Public Health Advisory that the smoking cessation drugs will be required to carry a stronger warning label.  

Last week, Britain's Committee on Safety of Medicines (CSM) announced that tougher warnings and prescription standards were needed to protect the health of those taking the popular anti-smoking drug Zyban. CSM said that additional Zyban warnings were needed in order to better educate both doctors and patients regardin

Zyban, manufactured by GlaxoSmithKline, has been prescribed to over 15 million people worldwide since winning approval from the U.S. Food and Drug Administration in 2000. The medication reduces the craving for nicotine that tobacco products produce. For patients in Britain, Zyban has been marketed as the first a

According to GlaxoSmithKline and the UK Department of Health, at present there is no link between reports of 18 deaths and the use of Zyban. "The contribution of Zyban to these deaths is unknown," commented the department. After the U.S. Food and Drug Administration approved Zyban in July 2000, several British genera

Zyban, manufactured by GlaxoSmithKline, has been taken by hundreds of thousands of people as an aid to help them stop smoking. Research indicates that one-third of all Zyban users quit smoking for more than a year. As such, Zyban appears to be twice as effective as nicotine patches. Despite this, some Zyban patient